Rapid Micro Biosystems FY 2021: revenue $23.2M; diluted EPS −$3.94
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001380106-22-000010
- Document
- 10-K
- Exhibit 4.6
- Warrants or notes
- Exhibit 10.15
- Material contract
- Exhibit 10.16
- Material contract
- Exhibit 10.17
- Material contract
- Exhibit 10.18
- Material contract
- Exhibit 10.19
- Material contract
Key figures from this report
These are the numbers Rapid Micro Biosystems reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$23.2MNo year-earlier figure tagged10-K income statement, on EDGAR
- Net income−$73.5MNo year-earlier figure tagged10-K income statement, on EDGAR
- Diluted EPS−$3.94No year-earlier figure tagged10-K income statement, on EDGAR
- Cash and cash equivalents$178.4MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
- Cash from operations−$55.0MNo year-earlier figure tagged10-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3826 and related industry codes: the same peer list as the financial tables.
- Hurco Companies HURC public float $101M, Apr 30, 2025, over 18 months old
- Owlet OWLT public float $96M, Jun 30, 2025
- Seer SEER public float $114M, Dec 31, 2025
- Geospace Technologies GEOS public float $90M, Mar 31, 2025, over 18 months old
- Intest INTT public float $85M, Jun 30, 2025
